Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2026-01-01 @ 8:05 PM
Study NCT ID:
NCT03588650
Status:
COMPLETED
Last Update Posted:
2022-06-03
First Post:
2018-06-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
Sponsor:
Shanghai Henlius Biotech
Organization: